Histological and immunohistochemical assessment of liver biopsies in morbidly obese patients

Histology and Histopathology

Volumn 27, Issue 4, 2012, Pages 459-466

  Caballero, T ^a,b   Gila, A ^b,c   Sanchez Salgado G ^a   Munoz de Rueda P ^b,c   Leon J ^b,c   Delgado, S ^c   Munoz J A ^b,c   Caba Molina, M ^a   Carazo, A ^b,c   Ruiz Extremera, A ^b   Salmeron J ^b,c  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Surgery Department   (Spain)

Author keywords

Immunohistochemistry; Morbid obesity; Multivesicular hepatocytesteatosis; Nafld; Portal inflammation

Indexed keywords

BIOLOGICAL MARKER; CD68 ANTIGEN, HUMAN; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN;

ADULT; AGE; ARTICLE; BARIATRIC SURGERY; BIOPSY; CELL NUCLEUS; FATTY LIVER; FEMALE; FIBROSIS; GRANULOMA; HUMAN; LIVER; LIVER CELL; MALE; METABOLISM; MIDDLE AGED; MORBID OBESITY; PATHOLOGY; PORTAL VEIN; SEX DIFFERENCE;

ADULT; AGE FACTORS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BARIATRIC SURGERY; BIOLOGICAL MARKERS; BIOPSY; CELL NUCLEUS; FATTY LIVER; FEMALE; FIBROSIS; GRANULOMA; HEPATOCYTES; HUMANS; LIVER; MALE; MIDDLE AGED; OBESITY, MORBID; PORTAL SYSTEM; SEX FACTORS;

EID: 84857750995     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Abraham S. and Furth E.E. (1994). Receiver operating characteristic analysis of glycogenated nuclei in liver biopsy specimens: quantitative evaluation of their relationship with diabetes and obesity. Hum. Pathol. 25, 1063-1068.
2. Abrams G.A., Kunde S.S., Lazenby A.J. and Clements R.H. (2004). Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease. Hepatology 40, 475-483.
3. Angulo P. (2006). NAFLD, obesity, and bariatric surgery. Gastroenterology 130, 1848-1852.
4. Arner P. (2003). The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones. Trends Endocrin. Met. 14, 137-145.
5. Arun J., Clements R.H., Lazenby A.J., Leeth R.R. and Abrams G.A. (2006). The prevalence of nonalcoholic steatohepatitis is greater in morbidly obese men compared to women. Obes. Surg. 16, 1351-1388
6. Bateman A.C. (2007). Patterns of histological change in liver disease: my approach to 'medical' liver biopsy reporting. Histopathology 51, 585-596.
7. Beymer C., Kowdley K.V., Larson A., Edmonson P., Dellinger E.P. and Flum D.R. (2003). Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery. Arch. Surg. 138, 1240-1244.
8. Bravo A.A., Sheth S.G. and Chopra S. (2001). Liver biopsy. N. Engl. J. Med. 344, 495-500.
9. Brunt E.M. (2009). Histopathology of non-alcoholic fatty liver disease. Clin. Liver Dis. 13, 533-544.
10. Brunt E.M. (2010). Pathology of non-alcoholic fatty liver disease. Nat. Rev. Gastroenterol. Hepatol. 7, 195-203.
11. Brunt E.M. and Tiniakos D.G. (2010). Histopathology of nonalcoholic fatty liver disease. World J. Gastroenterol. 16, 5286-5296.
12. Brunt E.M., Janney C.G., Di Bisceglie A.M., Neuschwander-Tetri B.A. and Bacon B.R. (1999). Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am. J. Gastroenterol. 94, 2467-2474.
13. Brunt E.M., Kleiner D.E., Wilson L.A., Unalp A., Behling C.E., Lavine J.E., Neuschwander-Tetri B.A. and the NASH Clinical Research Network (2009). Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLDClinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network. Hepatology 49, 809-820.
14. Carter-Kent C., Yerian L.M., Brunt E.M., Angulo P., Kohli R., Ling S.C., Xanthakos S.A., Whitington P.F., Charatcharoenwitthaya P., Yap J., Lopez R., McCullough A.J. and Feldstein A.E. (2009). Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study. Hepatology 50, 1113-1120.
15. Fotiadu A., Gagalis A., Akriviadis E., Kotoula V., Sinakos E., Karkavelas G. and Hytiroglou P. (2010). Clinicopathological correlations in a series of adult patients with non-alcoholic fatty liver disease. Pathol. Int. 60, 87-92.
16. Hashimoto E. and Tokushige K. (2011). Prevalence, gender, ethnic variations, and prognosis of NASH. J. Gastroenterol. 46 (Suppl 1), 63-69.
17. Hübscher S.G. (2006). Histological assessment of non-alcoholic fatty liver disease. Histopathology 49, 450-465.
18. Kleiner D.E., Brunt E.M., Van Natta M., Behling C., Contos M.J., Cummings O.W., Ferrell L.D., Liu Y.C., Torbenson M.S., Unalp-Arida A., Yeh M., McCullough A.J. and Sanyal A.J. (2005). Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313-1321.
19. Lefkowitch J.H., Haythe J. and Regent N. (2002). Kupffer cell aggregation and perivenular distribution in steatohepatitis. Mod. Pathol. 15, 699-704.
20. Levene A.P. and Goldin R.D. (2010). Physiological hepatic nuclear vacuolation-how long does it persist?. Histopathology 56, 426-429.
21. Liew P.L., Lee W.J., Lee Y.C., Wang H.H., Wang W. and Lin Y.C. (2006). Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease. Obes. Surg. 16, 1584-1593.
22. Machado M., Marques-Vidal P. and Cortez-Pinto H. (2006). Hepatic histology in obese patients undergoing bariatric surgery. J. Hepatol. 45, 600-606.
23. Ogden C.L., Carroll M.D., Curtin L.R., McDowell MA, Tabak C.J. and Flegal K.M (2006). Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295, 1549-1555.
24. Ong J.P., Elariny H., Collantes R., Younoszai A., Chandhoke V., Reines H.D., Goodman Z. and Yuonossi Z.M. (2005). Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Obes. Surg. 15, 310-315.
25. Rakha E.A., Adamson L., Bell E., Neal K., Ryder S.D., Kaye P.V. and Aithal G.P. (2010). Portal inflammation is associated with advanced histological changes in alcoholic and non-alcoholic fatty liver disease. J. Clin. Pathol. 63, 790-795.
26. Riley T.R. III and Ruggiero F.M. (2008). The effect of processing on liver biopsy core size. Dig. Dis. Sci. 53, 2775-2777.
27. Straub B.K. and Schirmacher P. (2010). Pathology and biopsy assessment of non-alcoholic fatty liver disease. Dig. Dis. 28, 197-202.
28. Schwimmer J.B., Behling C., Newbury R., Deutsch R., Nievergelt C., Schork N.J. and Lavine J.E. (2005). Histopathology of pediatricnonalcoholic fatty liver disease. Hepatology 42, 641-649.
29. Tiniakos D.G., Vos M.B. and Brunt E.M. (2010). Nonalcoholic fatty liver disease: pathology and pathogenesis. Annu. Rev. Pathol. Mech. Dis. 5,145-171.
30. Zatloukal K., French S.W., Stumptner C., Strnad P., Harada M., Toivola D.M., Cadrin M. and Omary M.B. (2007). From Mallory to Mallory-Denk bodies: What, how and why? Exper. Cell. Res. 313, 2033-2049.